These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5904206)

  • 1. Evaluation of fibrinolysis in hepatic cirrhosis. Relation of serial thrombin time and euglobulin lysis time.
    Brodsky I; Dennis LH
    Am J Clin Pathol; 1966 Jan; 45(1):61-9. PubMed ID: 5904206
    [No Abstract]   [Full Text] [Related]  

  • 2. FIBRINOLYTIC BLEEDING AND ITS MANAGEMENT.
    SHERRY S; FLETCHER AP; ALKJAERSIG N
    Ann N Y Acad Sci; 1964 Jul; 115():481-92. PubMed ID: 14192857
    [No Abstract]   [Full Text] [Related]  

  • 3. CIRCULATING FIBRINOLYTIC ACTIVATOR AND HEMORRHAGIC DIATHESIS.
    ENDE N; AUDITORE JV
    Ann Surg; 1963 Jul; 158(1):117-25. PubMed ID: 14042622
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical significance of accelerated fibrinolysis in liver disease.
    Francis RB; Feinstein DI
    Haemostasis; 1984; 14(6):460-5. PubMed ID: 6534818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amniotic fluid embolism. A case investigated by coagulation and fibrinolysis studies.
    Skjodt P
    Acta Obstet Gynecol Scand; 1965; 44(3):437-57. PubMed ID: 5863077
    [No Abstract]   [Full Text] [Related]  

  • 6. [Disorders of coagulation/fibrinolysis and bleeding tendency].
    Endo T; Amemiya N; Kume S
    Nihon Rinsho; 1994 Jan; 52(1):119-23. PubMed ID: 8114280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epsilon-aminocaproic acid for treatment of fibrinolysis during liver transplantation.
    Kang Y; Lewis JH; Navalgund A; Russell MW; Bontempo FA; Niren LS; Starzl TE
    Anesthesiology; 1987 Jun; 66(6):766-73. PubMed ID: 3296855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemorrhagic diathesis in cirrhosis of the liver].
    Tytgat GN; Collen DJ; De Vreker RA
    Nouv Rev Fr Hematol; 1968; 8(1):123-30. PubMed ID: 4232756
    [No Abstract]   [Full Text] [Related]  

  • 9. Coagulation studies in patients with cirrhosis of liver: bleeders vs non-bleeders.
    Rastogi P; Gupta SC; Bisht D
    Indian J Pathol Microbiol; 1990 Oct; 33(4):323-7. PubMed ID: 2132499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [BLOOD COAGULATION DISORDERS DURING LABOR WITH SPECIAL REFERENCE TO FIBRINOLYSIS].
    OPPELT HG; BECK L
    Geburtshilfe Frauenheilkd; 1965 Jan; 25():46-55. PubMed ID: 14262686
    [No Abstract]   [Full Text] [Related]  

  • 11. 2 CASES OF FIBRINOLYSIS DURING SHUNT OPERATION IN CIRRHOSIS OF THE LIVER.
    LEIBA H; RAMOT B; MANY A
    Isr Med J; 1964; 23():176-80. PubMed ID: 14215370
    [No Abstract]   [Full Text] [Related]  

  • 12. The 125I-fibrinogen euglobulin clot-lysis test.
    Horvath AE; Gralnick HR
    Am J Clin Pathol; 1978 Aug; 70(2):271-4. PubMed ID: 696685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gingival bleeding: the only sign in a case of fibrinolysis.
    Nichols C; Roller NW; Garfunkel A; Ship II
    Oral Surg Oral Med Oral Pathol; 1974 Nov; 38(5):681-90. PubMed ID: 4612434
    [No Abstract]   [Full Text] [Related]  

  • 14. [DISSOCIATED EFFECTS OF A NEW ANTIFIBRINOLYTIC AGENT (EPSILON-AMINOCAPROIC ACID) INJECTED "IN VIVO", ON "IN VITRO" FIBRINOLYSIS TESTS].
    WEISS M; YVER J; SAMAMA M; DUBOST C
    Presse Med (1893); 1963 Sep; 71():1879-80. PubMed ID: 14091607
    [No Abstract]   [Full Text] [Related]  

  • 15. Proteinase inhibitors in portasystemic shunts.
    Grossi CE; Prytz B; Rousselot LM
    Ann N Y Acad Sci; 1968 Jun; 146(2):777-87. PubMed ID: 5305819
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fibrinolysis in chronic liver diseases studied by in vitro blood coagulation tests].
    Pósán E; Tornai I; Udvardy M
    Orv Hetil; 1994 Dec; 135(51):2821-4. PubMed ID: 7838517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new euglobulin clot lysis assay for global fibrinolysis.
    Smith AA; Jacobson LJ; Miller BI; Hathaway WE; Manco-Johnson MJ
    Thromb Res; 2003; 112(5-6):329-37. PubMed ID: 15041279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on hemorrhagic tendency in cirrhosis of the liver.
    Yoshimura R; Asai H; Harihara S; Kamata T; Monna T; Yamamoto S; Fukuda T; Maeda H
    Gastroenterol Jpn; 1979 Aug; 14(4):353-65. PubMed ID: 90631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [EXISTENCE OF CHANGES IN HEMOSTASIS WITH DECREASED FIBRINOLYSIS. BASIS FOR THE HEMOSTATIC TREATMENT WITH EPSILON AMINOCAPROIC ACID IN NON FIBRINOLYTIC HEMORRHAGIC DIATHESIS].
    CASTILLO R; SERRANO J; CARALPS A; VINAS M
    Med Clin (Barc); 1963 Oct; 41():302-6. PubMed ID: 14125259
    [No Abstract]   [Full Text] [Related]  

  • 20. The euglobulin lysis time test: an ineffectual monitor of the therapeutic inhibition of fibrinolysis.
    Katz J; Lurie A; Becker D; Metz J
    J Clin Pathol; 1970 Sep; 23(6):529-32. PubMed ID: 4991001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.